Atenolol Should NOT Be Used for Acute Migraine Treatment in the Emergency Department
Atenolol has no role in the acute treatment of migraine in the ER setting. Beta-blockers like atenolol are preventive medications for episodic migraine, not abortive therapies for acute attacks. The FDA labeling for atenolol lists only hypertension, angina pectoris, and acute myocardial infarction as approved indications—migraine treatment is not among them 1.
Why This Matters
The most recent and comprehensive guidelines explicitly address acute migraine management in the emergency department without mentioning beta-blockers as treatment options. The 2025 American Headache Society guidelines for ED management provide clear evidence-based recommendations for parenteral therapies, and atenolol is conspicuously absent 2.
What SHOULD Be Used in the ER
First-Line Parenteral Options (Level A - Must Offer):
- Prochlorperazine IV - highly likely effective based on multiple class I studies 2, 3
- Greater occipital nerve blocks (GONB) - highly likely effective 2
Second-Line Options (Level B - Should Offer):
- Metoclopramide IV - likely effective, supported by class I evidence 2, 3
- Dexketoprofen IV - highly likely effective 2
- Ketorolac IV - likely effective 2
- Sumatriptan subcutaneous - highly likely effective 2, 3
- Supraorbital nerve blocks (SONB) - likely effective 2
Additional Considerations:
Critical Pitfall: Avoid Opioids
Hydromorphone IV must NOT be offered (Level A) 2. Opioids like morphine and hydromorphone are less effective at terminating acute migraines, result in prolonged ED visits, and carry significant risks of dependence and medication overuse headache 3, 4, 5. The 2025 ACP guidelines explicitly state: "Do not use opioids or butalbital for the treatment of acute episodic migraine" 6.
The Role of Beta-Blockers in Migraine
Beta-blockers, including atenolol, are preventive medications for episodic migraine, not acute treatments. The 2002 guidelines note limited evidence for atenolol in migraine prevention (50-100 mg daily), with propranolol and timolol having stronger evidence 7. One small 2013 open-label study showed atenolol 50 mg daily reduced chronic migraine frequency over 3 months 8, but this addresses prevention, not acute attacks.
Practical Algorithm for ER Migraine Treatment
- Start with dopamine antagonist: Prochlorperazine 10 mg IV or metoclopramide 10-20 mg IV
- Add antiemetic if needed: For nausea/vomiting
- Consider nerve block: GONB or SONB for rapid relief
- Alternative if contraindications exist: Ketorolac 30 mg IV or dexketoprofen IV
- Discharge with dexamethasone: 10-24 mg IV/IM to prevent recurrence
- Avoid: Opioids, butalbital, propofol, paracetamol IV (likely ineffective) 2
The evidence is unequivocal: atenolol belongs in the outpatient preventive setting, not the emergency department for acute migraine management.